Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era.

FDA staffers in the Center for Devices and Radiological Health told NBC News that their AI pilot, CDRH-GPT, is buggy, isn't ...

The U.S. FDA announced this week that it deployed a generative AI tool called ELSA, now in use by staff across the agency, ...

Finally, sources told WSJ that Witty didn't have a background in the U.S. insurance industry; he was formerly the CEO of ...

The U.S. Food and Drug Administration said on Monday that it had launched a generative AI tool, Elsa, aimed at improving ...

Alex Ratner, CEO of Snorkel AI, remembers a time when data labeling —the grueling task of adding context to swathes of raw ...

The agency has provided few details about its AI pilot as it makes moves on its “aggressive timeline” for rollout.

The agency has provided only limited details about its AI pilot as it advances an “aggressive timeline” for the tool's ...

FDA employees report the agency's new AI assistant produces incorrect answers and lacks essential safeguards. (Shutterstock) ...

The FDA has introduced ELSA, a groundbreaking AI tool designed to expedite the review process for drugs and medical devices.

The FDA is using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations and identify high-priority inspection targets.

The Food and Drug Administration has officially launched "Elsa," a generative artificial intelligence platform designed to ...